Ohr Pharmaceutical Inc (OHRP) has 24 open-market insider trades by 7 insiders since 2014. The most active filer is Jason Scott Slakter, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Jason Scott Slakter | CEO | — | 10 | $651K | 2017-04-10 |
| Orin Hirschman | Dir | — | 2 | $340K | 2017-04-10 |
| Samuel Backenroth | CFO | — | 4 | $125K | 2017-04-10 |
| June Sherie Almenoff | Dir | — | 3 | $124K | 2015-02-06 |
| Thomas M. Riedhammer | Dir | — | 2 | $62K | 2014-06-25 |
| Ira A. Greenstein | Dir | — | 2 | $34K | 2015-01-15 |
| Irach B. Taraporewala | CEO | — | 1 | $25K | 2015-02-06 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Orin Hirschman | Director | Buy | $100K | 2017-04-10 |
| Orin Hirschman | Director | Buy | $240K | 2017-04-10 |
| Jason Scott Slakter | CEO | Buy | $200K | 2017-04-10 |
| Samuel Backenroth | CFO | Buy | $100K | 2017-04-10 |
| Samuel Backenroth | CFO | Buy | $7K | 2016-06-20 |
| Jason Scott Slakter | CEO | Buy | $25K | 2016-06-20 |
Companies that share insiders with OHRP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Jason Scott Slakter | CEO | Buy | $11K | 2016-05-25 |
| Jason Scott Slakter | CEO | Buy | $89K | 2016-05-23 |
| Samuel Backenroth | CFO | Buy | $8K | 2016-05-23 |
| Jason Scott Slakter | CEO | Buy | $21K | 2016-04-11 |
| Jason Scott Slakter | CEO | Buy | $23K | 2016-03-07 |
| Jason Scott Slakter | CEO | Buy | $19K | 2016-02-22 |
| Jason Scott Slakter | CEO | Buy | $23K | 2016-01-19 |
| Jason Scott Slakter | CEO | Buy | $12K | 2015-12-07 |
| Jason Scott Slakter | CEO | Buy | $39K | 2015-11-02 |